Physician profile
Robert B Mullan
NPI 1033105812
$31,430.10
in general payments reported to CMS, 2019-2025
30 companies · $16K in 2025
The $16K reported for 2025 was more than what 98% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $448 · 2021: $1,128 · 2022: $360 · 2023: $1,453 · 2024: $63.99 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $16K · Food and Beverage: $1,663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $16,000.00 |
| Food and Beverage | $1,662.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $16,390.92 | 2019-2025 | Puraply |
| Flower Orthopedics Coporation | $7,342.15 | 2019 | |
| Arthrosurface Incorporated | $2,402.18 | 2019 | |
| Zimmer Biomet Holdings, INC. | $835.63 | 2019-2021 | |
| 4web, INC. | $781.50 | 2019-2021 | |
| Djo, LLC | $630.64 | 2019 | |
| Progenacare Global, LLC | $476.25 | 2023 | |
| Kerecis Limited | $421.86 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Ossio INC | $398.20 | 2023 | |
| Vaporox, INC. | $372.89 | 2023 | Vht-200 Wound Treatment System |
| Smith+Nephew, INC. | $324.24 | 2019-2025 | Collagenase Santyl |
| Kci USA, INC. | $158.38 | 2019 | |
| Abbvie INC. | $132.52 | 2021-2022 | |
| Fusion Orthopedics USA, LLC | $107.87 | 2023 | |
| Grt US Holding, INC. | $87.29 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $71.96 | 2019 | |
| Paragon 28, INC. | $65.75 | 2021 | |
| Medshape, INC. | $63.88 | 2020 | |
| Tactile Systems Technology INC | $56.21 | 2019-2021 | |
| Biowound Solutions, INC. | $51.77 | 2025 | Bio-Connekt |
| Paratek Pharmaceuticals, INC. | $47.73 | 2024-2025 | Nuzyra |
| Orthofix Medical, INC. | $46.69 | 2021-2023 | Physio-Stim |
| Averitas Pharma INC. | $38.15 | 2023-2024 | Qutenza |
| Reprise Biomedical, INC. | $29.04 | 2025 | Miro3d |
| Depuy Synthes Sales INC. | $19.53 | 2025 | Motoband |
| Integra Lifesciences Corporation | $17.34 | 2019 | |
| Acera Surgical, INC. | $16.19 | 2020 | |
| Bioventus LLC | $16.03 | 2021 | |
| Crossroads Extremity Systems, LLC | $15.96 | 2020 | |
| Merck Sharp & Dohme LLC | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mullan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.